期刊文献+

缺血修饰白蛋白评估动脉瘤性蛛网膜下腔出血患者迟发性脑缺血研究 被引量:9

Value of ischemia-modified albumin in evaluating delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage
在线阅读 下载PDF
导出
摘要 目的探讨缺血修饰白蛋白(IMA)评估动脉瘤性蛛网膜下腔出血(a SAH)患者迟发性脑缺血(DCI)的价值及其与患者预后的关系。方法选取198例a SAH患者,根据有无DCI把患者分为DCI组和无DCI组,测定血清IMA,同时使用经颅多普勒(TCD)监测大脑中动脉的平均血流速度(VMCA),比较两组脑血管痉挛发生率和血清IMA。结果在7~10天时间段VMCA和血清IMA达到峰值,然后逐渐下降;在1~6天、7~10天、11~14天时间段,VMCA比较、血清IMA比较,差异均有统计学意义(P <0. 05)。DCI组的CVS发生率高于无DCI组,并且DCI组的血清IMA水平高于无DCI组,差异均有统计学意义(P <0. 05)。预后不良组的血清IMA[(64. 28±5. 94) U/ml]高于预后良好组[(45. 46±5. 72) U/ml],差异有统计学意义(P <0. 05)。结论血清IMA水平与脑血管痉挛及预后密切相关,它可在一定程度上反应a SAH后脑缺血情况,对血管痉挛相关的DCI评估有重要价值,并且有助于判断预后。 Objective To investigate the value of ischemia-modified albumin( IMA) in evaluating delayed cerebral ischemia( DCI) in patients with aneurysmal subarachnoid hemorrhage( a SAH) and its association with patient prognosis. Methods A total of 198 patients with a SAH were enrolled,and according to the presence or absence of DCI,these patients were divided into DCI group and nonDCI group. Serum IMA was measured,and transcranial Doppler was used to monitor the mean blood flow velocity of the middle cerebral artery( VMCA). The incidence rate of cerebral vasospasm( CVS) and serum IMA were compared between the two groups. Results VMCA and serum IMA reached the peak on days 7-10,followed by a gradual reduction. There were significant differences in VMCA and serum IMA across days 1-6,7-10,and 11-14( P < 0. 05). Compared with the non-DCI group,the DCI group had significantly higher incidence rate of CVS and serum IMA level( P < 0. 05). The poor prognosis group had a significantly higher serum IMA level than the good prognosis group(64. 28 ± 5. 94 U/ml vs 45. 46 ± 5. 72 U/ml,P < 0. 05). Conclusions Serum IMA level is closely associated with CVS and prognosis,and to a certain extent,it can reflect the severity of cerebral ischemia after a SAH. The evaluation of vasospasm-related DCI has an important value in prognosis prediction.
作者 陈华轩 云德波 邓学云 罗波 李林 尚彬 范润金 CHEN Hua-xuan;YUN De-bo;DENG Xue-ytm;LUO Bo;LI Lin;SHANG Bin;FAN Run-Jin(Department of Neurosurgery,Nanchong Central Hospital,Nanchong ,Sichuan,637000,China)
出处 《国际神经病学神经外科学杂志》 2018年第6期597-599,共3页 Journal of International Neurology and Neurosurgery
关键词 迟发性脑缺血 缺血修饰白蛋白 动脉瘤性蛛网膜下腔出血 预后 Delayed cerebral ischemia Ischemia-modified albumin Aneurysmal subarachnoid hemorrhage Prognosis
作者简介 陈华轩(1984-),男,硕士,主治医师,主要从事脑血管疾病、颅脑创伤等方面研究。
  • 相关文献

参考文献5

二级参考文献42

  • 1唐晓斌,王英侠,刘庆国,徐赫男,徐艳云.缺血修饰白蛋白在急性缺血性脑血管病早期诊断中的应用[J].中华临床医师杂志(电子版),2011,5(16):4882-4884. 被引量:5
  • 2姚红,季立兰,冯汝军,迟兆富.TCD动态观察局部亚低温对蛛网膜下腔出血后脑血管痉挛的影响[J].山东医药,2005,45(19):6-7. 被引量:1
  • 3惠品晶,陆士奇,冀勇,王中,刘春风,惠国桢.兔蛛网膜下腔出血后脑血管痉挛的血流动力学变化[J].中华实验外科杂志,2005,22(9):1142-1142. 被引量:7
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33148
  • 5Sacchetti A. Ischemia modified albumin: a new biochemical marker of myocardial ischemia[J]. Emerg Med J, 2004, 21 : 3- 4.
  • 6Bar-Or D,Lau E, Winkler JV. A novel assay for cobalt-albu- min binding and its potential as a marker for myocardial ische- mia a preliminary report[J]. J Emerg Med, 2000, 19; 311- 315.
  • 7Sharma R, Gaze DC, Pellerin D, et al. Evaluation of ischae-mia-modified albumin as a marker of myocardial ischaemia in end-stage renaldisease[J]. Clin Sci(Lond), 2007, 113, 25- 32.
  • 8Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modi- fled albumin in acute stroke[J]. Cerebrovasc Dis, 2007, 23:216-220.
  • 9Gunduz A, Turedi S, Mentese A, et al. Ischemia-modified al- bumin in the diagnosis of acute mesenteric ischemia: a prelimi nary study[J]. Am J Emerg Med, 2008, 26:202-205.
  • 10Gidenne S, Ceppa F, Fontan E, et al. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MI- RA Plus analyzer[J]. Clin Chem Lab Med, 2004, 42: 455- 461.

共引文献44

同被引文献91

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部